Treatment of MRSA infection in orthopedic surgery;Behandlung der MRSA-infektion in der septischen extremitätenchirurgie

Chirurg

Volumn 75, Issue 3, 2004, Pages 269-275

  Muckley Th ^a,b   Hierholzer, Ch ^a   Diefenbeck, M ^a   Hofmann, G O ^a   Buhren V ^a  

^a Berufsgenossenschaftliche U ^*  (Germany)

^b BG UNFALLKLINIK MURNAU   (Germany)

Author keywords

Debridement; MRSA; Septic reconstructive orthopedic surgery; Treatment concept; Wound infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; FOLLOW UP; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ORTHOPEDIC SURGERY; RECURRENT DISEASE; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TREATMENT OUTCOME; VACUUM; WOUND CARE; WOUND CLOSURE; ARM INJURY; CHRONIC DISEASE; CROSS INFECTION; GERMANY; INTRAVENOUS DRUG ADMINISTRATION; LEG INJURY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIMODALITY CANCER THERAPY; PROTECTIVE CLOTHING; REOPERATION; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ARM INJURIES; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CROSS INFECTION; DEBRIDEMENT; DRUG RESISTANCE, MULTIPLE; FEMALE; GERMANY; HUMANS; INFUSIONS, INTRAVENOUS; LEG INJURIES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OCCLUSIVE DRESSINGS; RECURRENCE; REOPERATION; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 4143054538     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-003-0753-0     Document Type: Article

References (37)

1. Arens S (2002) Osteitis - immer noch ein Problem? Trauma Berufskrankh 4:295
2. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C (1999) Control of endemic Methicillin-resistant Staphylococcus aureus: a cost benefit analysis in an intensive care unit. JAMA 282:1745
3. Daschner F, Schumpelick V (2002) MRSA als Herausforderung an die klinische Organisation. Chirurg 73:924
4. Farr BM, Salgado CD, Karchmer TB, Sherertz RJ (2001) Can antibiotic-resistant nosocomial infections be controlled? Lancet Infect Dis 1:38
5. Gottlieb S (2003) CDC reports first case of vancomycin resistant Staphylococcus aureus. Br Med J 326:783
6. Griffiths-Jones A (1995) Methicllin-resistant Staphylococcus aureus in wound care. J Wound Care 4:481
7. Haley RW (1991) Methicillin-resistant Staphylococcus aureus: do we just have to live with it? Ann Intern Med 114:162
8. Hayes PD, Nasim A, London NJ, Sayers RD et al. (1999) In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 30:92
9. Hornberg C, Koller A, Bühring W, Bösenberg H, Wetz HH (2001) Methicillin-resistenter Styphylococcus aureus (MRSA). Aktuelle Situation und Bedeutung der Infektionsprävention in der Technischen Orthopädie. Orthopäde 30:231
10. Hornberg C, Koller A, Kipp F, Bühring W, Wetz HH (2001) Häufigkeit und Erfassung nosokomialer Infektionen in der Technischen Orthopädie. Orthopäde 30:176
11. Hutchinson JJ, Lawrence JC (1991) Wound infection under occlusive dressings. J Hosp Infect 17:83
12. Jevons MP (1961) Celbenin-resistant staphylococci. Br Med J 1:124
13. Keane CT (1993) Methicillin-resistant Staphylococcus aureus (MRSA). Ir Med J 86:164
14. Kilgus DJ, Howe DJ, Strang A (2002) Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop 404:116
15. König DP, Randerath O, Hackenbroch MH (1999) Nosokomiale Infektionen mit Methicillin-resistenten Staphylococcus aureus (MRSA) und -epidermidis (MRSE) Stämmen. Bedeutung, Prophylaxe und Therapie in der Knochenchirurgie. Unfallchirurg 102:324
16. Kreutzer J, Nußbaum B, Bernd L, Simank HG (2002) Reale Kosten der MRSA-Osteitis - eine retrospektive Studie im Zeitraum von 1996-2001. Trauma Berufskrankh 4:344
17. Lawrence JC (1993) Reducing the spread of bacteria. J Wound Care 2:48
18. Li Z, Willke RJ, Pinto LA, Rittenhouse BE et al. (2001) Comparison of length of hospital stay for patients with known or suspected Methicillin-resistant Staphylococcus species infections treated with Linezolid or Vancomycin: a randomized, multicenter trial. Pharmacotherapy 21:263
19. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250
20. Mertz PM, Ovington LG (1993) Wound healing microbiology. Dermatol Clin 11:739
21. Murphy GJ, Pararajasingam R, Nasim A, Dennis MJ, Sayers RD (2001) Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl 83:158
22. Nasim A, Thompson MM, Naylor AR, Bell PR, London NJ (2001) The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg 22:211
23. Nichols RL (1998) Postoperative infections in the age of drug-resistant gram-positive bacteria. Am J Med 104:11
24. Peltroche-Llacsahuanga H, Haase G, Lutticken R (1998) Methicillin-resistente Staphylococcus aureus (MRSA) - Klinische Implikationen. Chirurg 69:801
25. Perl TM, Roy MC (1995) Postoperative wound infections: risk factors and role of Staphylococcus aureus nasal carriage. J Chemother 7 [Suppl 3]: 29
26. Pittet D, Hugonnet S, Harbarth S, Mourouga P et al. (2000) Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection control programme. Lancet 356:1307
27. Prokop A, Isenberg J, Seifert H, Wenchel HM, Rehm KE (2002) Linezolid - ein neues Antibiotikum zur Behandlung von MRSA-Infektionen in der Unfallchirurgie? 2 Fallberichte. Unfallchirurg 105:287
28. Robert Koch Institut (2003) Methicillin-resistente Staphylococcus aureus (MRSA) in deutschen Alten- und Pflegeheimen - zur Situation. Epidemiol Bull 19:145
29. Robert Koch Institut (2003) Screening bei MRSA-Risikopatienten in einem Berliner Krankenhaus. Epidemiol Bull 19:148
30. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ (1995) Mortality associated with nosocomial bacteremia due to Methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21:1417
31. Stark M, Heeg P (2002) Klinische Aspekte von Infektionen durch Methicillin-resistente Staphylococcus aureus. Akt Traumatol 32:258
32. Teepe R, Koebrugge E, Löwik C, Petit P et al. (1993) Cytotoxic effects of topical antimicrobial and antiseptic agents on human keratinocytes in vitro. J Trauma 35:8
33. Torsello G, Sandmann W (1997) Use of antibiotic-bonded grafts in vascular graft infection. Eur J Vasc Endovasc Surg 14 [Suppl A]: 84
34. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM et al. (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207
35. Wendt C, Martiny H (2000) Die Sanierung von MRSA-Patienten - Stand des Wissens. Hyg Med 25:355
36. Witte W, Braulke C, Heuck D (2000) MRSA-Situation in Deutschland. Hyg Med 25:347
37. Young T (1996) Methicillin-resistant Staphylococcus aureus. J Wound Care 5:475